Nineteen patients (67.9%) with IDH mutant GA and 25 cases (89.3%) of IDH mutant Astrocytoma reported a history of adjuvant therapy for their disease. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).